Back To Top

Kyongbo Pharm's production facilities receive FDA approval

[DISCLOSURE] Kyongbo Pharmaceutical (214390) announced on June 27 that its GMP production facilities have been approved by USFDA. The pharmaceutical company had applied for FDA inspection to export its antibiotics raw material in February.
MOST POPULAR
LATEST NEWS
subscribe
소아쌤